| Institution: | 1. Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven, Belgium;2. Departments of Gynaecology and Obstetrics, UZ Leuven, Leuven, Belgium;3. General Medical Oncology, UZ Leuven, Leuven, Belgium;4. Medical Oncology Department, Maastricht University Medical Center (MUMC), School of GROW, Maastricht, The Netherlands;5. The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK;6. Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands;7. Departments of Medical Oncology, Amsterdam, The Netherlands;8. Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands;9. Department of Medical Oncology, Institut Curie, UVSQ/Paris-Saclav University, Paris, France;10. Departments of Radiology, UZ Leuven, Leuven, Belgium;11. Pathology, UZ Leuven, Leuven, Belgium;12. Surgical Oncology, UZ Leuven, Leuven, Belgium;13. Departments of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;14. Tumour Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;15. Department of Pathology, Institut Curie, Paris, France;16. Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland;17. School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy’s Cancer Centre, King’s College London, London, UK |
